BNC Share Price

Open 21.52 Change Price %
High 21.52 1 Day 0.00 0.00
Low 21.52 1 Week 0.00 0.00
Close 21.52 1 Month -0.18 -0.83
Volume 810 1 Year 21.31 10147.62
52 Week High 23.18
52 Week Low 20.15
BNC Important Levels
Resistance 2 21.52
Resistance 1 21.52
Pivot 21.52
Support 1 21.52
Support 2 21.52
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BBD-B 2.66 1.14%
SC 60.83 -0.44%
PRE 0.64 0.00%
PRE 0.64 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
AVP 0.06 20.00%
AVP 0.06 20.00%
AVP 0.06 20.00%
AVP 0.06 20.00%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
HYD 0.26 -13.33%
HYD 0.26 -13.33%
IMP 0.08 -11.11%
IMP 0.08 -11.11%
IMP 0.08 -11.11%
CTU-A 0.19 -9.52%
RN 0.11 -8.33%
RN 0.11 -8.33%
KAT 0.66 -8.33%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 11th Aug 2017 BNC Share Price closed @ 21.52 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.32 & Strong Buy for SHORT-TERM with Stoploss of 17.56 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
TD Asset Management Inc. Announces Monthly Distribution for August 2017   Markets Insider   - 18th Aug 17
Swedroe: More On Active Share Debate   ETF.com   - 18th Aug 17
PURPOSE CDN FINANCIAL INCOME FUND ETF (BNC) Is Yet to See Trading Action on Aug 17   San Times   - 17th Aug 17
PURPOSE CDN FINANCIAL INCOME FUND ETF (BNC) Is Yet to See Trading Action on Aug 3   MoneyMakingArticles   - 03rd Aug 17
BlackRock® Canada Announces July Cash Distributions for the iShares® ETFs   GlobeNewswire (press release)   - 13th Jul 17
Purpose Investments Inc. Announces June Distributions   Marketwired (press release)   - 22nd Jun 17
The MoneyShow Toronto   Moneyshow.com (registration)   - 23rd Feb 17
3 Bulletproof ETFs For Income In 2017   Forbes   - 01st Feb 17
Purpose Investments Announces the Launch of Two Innovative Income Funds   Marketwired (press release)   - 26th Oct 16
Is my ETF's yield too good to be true?   The Globe and Mail   - 15th Oct 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.